Current Review of Implantable Cardioverter Defibrillator Use in Patients With Left Ventricular Assist Device
- 25 November 2019
- journal article
- review article
- Published by Springer Nature in Current Heart Failure Reports
- Vol. 16 (6) , 229-239
Abstract
While use of implantable cardioverter defibrillator (ICD) in patients with heart failure (HF) and reduced ejection fraction is recommended, their role in patients with left ventricular assist device (LVAD) remains controversial, especially with continuous flow (CF) devices.Keywords
This publication has 83 references indexed in Scilit:
- Management of Patients with Heart Failure: Focus on New Pharmaceutical and Device OptionsCurrent Medicinal Chemistry, 2020
- Effectiveness of an Intervention Supporting Shared Decision Making for Destination Therapy Left Ventricular Assist DeviceJAMA Internal Medicine, 2018
- The role of implantable cardioverter-defibrillators in patients with continuous flow left ventricular assist devices — A meta-analysisInternational Journal of Cardiology, 2016
- Asymptomatic Sustained Polymorphic Ventricular Tachycardia in a Patient with a Left Ventricular Assist Device: Case Report and what the Emergency Physician Should KnowThe Journal of Emergency Medicine, 2016
- Heart Failure–Associated Hospitalizations in the United StatesJACC, 2013
- Epidemiology, management, and outcomes of sustained ventricular arrhythmias after continuous-flow left ventricular assist device implantationAmerican Heart Journal, 2012
- Heart Disease and Stroke Statistics—2012 UpdateCirculation, 2012
- Clinical epidemiology of heart failureHeart, 2007
- Prediction and prevention of sudden cardiac death in heart failureHeart, 2005
- Long-Term Use of a Left Ventricular Assist Device for End-Stage Heart FailureNew England Journal of Medicine, 2001